IBERSOL | Integrated Management Report - 2024

Consolidated Financial Statements significantly from the value at which it was carried, thus resulting in no impact on the income statement. The impact of the acquisition of the subsidiary Medfood on the Consolidated Income Statement and Other Comprehensive Income as in 31 December 2024, is as follows: 6 months ended 31/12/2024 Sales 21 303 522 Rendered services 41 293 Cost of sales -5 474 750 External supplies and services -6 206 772 Payrolll costs -6 167 540 Amortisation, depreciation and impairment losses of TFA, Rights of Use, Goodwill and IA -2 597 729 Other operating gains (losses) -301 325 Operating Income 596 699 Financial expenses and losses -1 015 791 Profit before tax -419 092 Income tax -23 280 Net profit -442 372 6.2. Goodwill Accounting policies Recognition Goodwill represents the excess of acquisition cost over the fair value of identifiable assets and liabilities attributable to the Group at the date of acquisition or first con- solidation. If the acquisition cost is lower than the fair value of the acquired subsidi- ary’s net assets, the difference is recognized directly in profit or loss for the year. Goodwill is allocated to the Group’s cash generating units (or group of units), identi- fied in each business segment. Impairment The Group performs impairment tests on Goodwill on an annual basis or more fre- quently if events or changes in circumstances indicate a potential impairment. The recognized amount of Goodwill is compared with the recoverable amount, which is the higher of value in use and fair value less costs to sell. 400